Medscape Medical News
- FDA OKs Selpercatinib for Adults With RET Fusion+ Solid Tumors
- Alert FDA Okays Terlipressin (Terlivaz) for Hepatorenal Syndrome
- FDA Approves Pascal Precision System for Mitral Regurgitation
- Alert FDA Approves Oral TYK2 Inhibitor for Treating Psoriasis
- Alert FDA Approves Durvalumab Plus Chemo for Biliary Tract Cancer
- Alert FDA Okays First Treatment for Generalized Pustular Psoriasis
- Alert FDA OKs First Targeted Agent, Pemigatinib, for Rare Blood Cancer
- Alert Ibrutinib Now Approved for Children With Chronic GVHD
- Alert FDA Clears Tubeless, Automated Insulin System for Kids 2 and Older
- Alert FDA Clears New Neurostimulation System for Chronic Pain
- Alert FDA Approves 'Rapid-Acting' Oral Drug for Major Depression
- FDA Approves First Gene Therapy for Beta-Thalassemia
- Alert FDA Approves Adalimumab Biosimilar in High-Concentration Form
- Alert Xofluza Approved for Treating Flu in Children
- Alert New Mismatch Repair Test Identifies Patients for Pembrolizumab
- Alert FDA Approves First Drug for HER2 Lung Cancer
- Alert FDA Authorizes Intradermal Use of Jynneos Vaccine for Monkeypox
- FDA Okays Tablet Version of Acalabrutinib for All Indications
- Alert FDA Okays First Targeted Agent for HER2-Low Breast Cancer
- Alert Ustekinumab Becomes Second Biologic Approved for PsA in Kids